Drug Shortage Report for AMINOPHYLLINE INJECTION USP

Last updated on 2023-05-19 History
Report ID 178367
Drug Identification Number 00497193
Brand name AMINOPHYLLINE INJECTION USP
Common or Proper name AMINOPHYLLINE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) AMINOPHYLLINE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 25 X 10Ml amp
ATC code R03DA
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-01-31
Estimated end date
Actual end date 2023-05-18
Shortage status Resolved
Updated date 2023-05-19
Company comments Product is discontinued
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2023-05-19 French Compare
v4 2023-05-19 English Compare
v3 2023-02-01 English Compare
v2 2022-12-14 French Compare
v1 2022-12-14 English Compare

Showing 1 to 5 of 5